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Abstract
Dicationic alkylammonium bromide gemini surfactants represent a class of amphiphiles potentially effective as skin
permeation enhancers. However, only a limited number of studies has been dedicated to the evaluation of the respective
cytotoxicity, and none directed to skin irritation endpoints. Supported on a cell viability study, the cytotoxicity of gemini
surfactants of variable tail and spacer length was assessed. For this purpose, keratinocyte cells from human skin (NCTC 2544
cell line), frequently used as a model for skin irritation, were employed. The impact of the different gemini surfactants on the
permeability and morphology of model vesicles was additionally investigated by measuring the leakage of calcein
fluorescent dye and analyzing the NMR spectra of
31P, respectively. Detail on the interaction of gemini molecules with
model membranes was also provided by a systematic differential scanning calorimetry (DSC) and molecular dynamics (MD)
simulation. An irreversible impact on the viability of the NCTC 2544 cell line was observed for gemini concentrations higher
than 25 mM, while no cytotoxicity was found for any of the surfactants in a concentration range up to 10 mM. A higher
cytotoxicity was also found for gemini surfactants presenting longer spacer and shorter tails. The same trend was obtained
in the calorimetric and permeability studies, with the gemini of longest spacer promoting the highest degree of membrane
destabilization. Additional structural and dynamical characterization of the various systems, obtained by
31P NMR and MD,
provide some insight on the relationship between the architecture of gemini surfactants and the respective perturbation
mechanism.
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Introduction
Transdermal drug delivery has been indicated as one of the most
promising routes for drug administration. Although the actual barrier
function of the skin limits the permeation of drugs, some chemical
compounds with the ability to modulate skin properties have been
proposedinorderto improveskin permeation and achievetherapeutic
doses of the drug [1]. However, chemical permeation enhancers
(CPE) reduce skin diffusional resistance by reversibly altering the
physicochemical properties of the stratum corneum. Therefore, a
major consequence is that CPE may cause damage and skin irritation,
limiting their usefulness for therapeutical application [2].
Amphiphiles, in general, are known to influence the organiza-
tion of lipid membranes and, particularly, surfactants have been
subjected to intense study in systems involving interaction with
lipid membranes [3]. Those of positive charge are typically more
effective as permeation enhancers than the alternative anionic and
nonionic compounds, although cytotoxicity is potentially more
significant in cationic systems [4,5]. Among several classes of
surface-active compounds, dicationic alkylammonium bromide
gemini surfactants were chosen, since they are known to efficiently
modulate the order in biomembranes as indicated in a previous
publication by some of the authors [6].
Gemini surfactants are a class of amphiphiles constituted by two
hydrophobic tails and two hydrophilic headgroups covalently
connected by a spacer. From a structural perspective, they can be
thought of as two single-tail surfactants connected by a spacer that
may present variations in terms of hydrophobicity, length and
rigidity [7,8]. In the last two decades, many contributions have
been made on the characterization of these materials from a
colloidal perspective [9,10]. The assessment of biological effects
[11,12] and respective interaction with polymers [13] and other
relevant biological molecules [14] have also been reported. The
simplest and most studied cationic gemini surfactants are the qua-
ternary ammonium compounds [15], represented by the general
structure
½CmH2mz1(CH3)2Nz(CH2)sNz(CH3)2CmH2mz1 2Br{
These surfactant molecules, often simplified to m-s-m, present
two identical ammonium head groups connected by a saturated
alkyl chain spacer with s carbons, and two symmetric saturated
alkyl tails comprising m carbons. Interesting aggregation proper-
ties have been attributed to these molecules, characterized by very
low critical micelle concentration (CMC) values [9,10,15], when
contrasted to their single-tail counterpart, such as dodecyltri-
methylammonium bromide (DTAB) [7].
As far as dicationic alkylammonium bromide gemini surfactants
are concerned, only a limited number of studies on the cytotoxicity
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ledge, has been directed to the effect upon the skin. In a previous
study, in which the same type of gemini surfactants (m-4-m, m=8,
11, 13, 16) was assessed on erythrocyte cells [16], the results
indicate that gemini disturb human erythrocytes and that the
hemolytic potency increases as the alkyl chain length increases. It
has also been suggested that m-4-m gemini surfactants disturb the
membrane in a way similar to single-chain cationic amphiphiles,
but that they do not easily translocate to the inner membrane
leaflet. Also, in a very recent work conducted by some of the
authors, complexes of 14-2-14:DNA and different formulations
containing cholesterol (Chol) and Chol:DOPE were assessed in
terms of cytoxicity upon TSA cells [17]. In this case, a relatively
low toxicity level has been found.
Evaluation of skin irritation has traditionally been conducted in
animals. However, beyond the obvious ethical implications, in vivo
tests present several disadvantages concerning reproducibility
and cost. Furthermore, the increasing knowledge of the basic
mechanisms of cutaneous inflammation and advanced techniques
to cultivate human skin cells led to the recommendation of ex vivo
approaches as an alternative to animal testing [18]. Skin irritation
is a reversible inflammatory reaction produced by the arachidonic
acid cascade and cytokines in the viable keratinocytes and fi-
broblasts of the skin [19]. Therefore, the assessment of potential
skin irritation of surfactants resorting to human keratinocytes has
been extensively used [19–22].
Inthiswork,keratinocytecellsfromthehumanskin(NCTC2544
cell line) were used as a model for skin irritation studies, while a
resazurine test [23] was used to evaluate the cell viability after 24 h
of gemini surfactants exposition. The ability of cells to recover after
removing the aggression agent was also evaluated 48 h later.
Resorting to a systematic DSC study [6] and a fluorescent dye-
leakage assay [24], the mechanism of membrane disruption was
additionally investigated by inspecting phase transition and per-
meability changes induced by gemini surfactants on model vesicles.
The effect of spacer and tail length on the morphology of model
vesicles was also addressed by
31P NMR [25]. Insight on the
interaction scheme was concomitantly provided by standard MD
simulations carried out on a fully hydrated bilayer interacting with
selected gemini surfactant molecules.
Materials and Methods
Materials
Cationic gemini surfactants, dimethylene bis (alkyldimethylammo-
nium bromide), m-2-m for m~12, 14, and 18, and alkylene bis
(dodecyldimethylammonium bromide), 12-s-12 for s~2, 6 and 10,
were synthesized and purified according to standard methods[26–28].
The high purity of the products was ascertained by NMR, elemental
analysis, surface tension and differential scanning calorimetry.
Citotoxicity
Cell culture. NCTC 2544 cells (human skin keratinocyte cell
line) [29,30] were maintained in culture at 37uC, under 5% CO2,
in RPMI-1640 medium (Sigma, St. Louis, MO) supplemented
with 10% (v/v) heat-inactivated fetal bovine serum (FBS) (Sigma,
St. Louis, MO), penicillin (100 U/mL) and streptomycin (100 mg/
mL). NCTC 2544 cells grow in monolayer and were detached by
treatment with a trypsin solution (0.25%) (Sigma, St. Louis, MO).
Cell viability assay. The cytotoxicity of gemini surfactants
was evaluated in NCTC 2544 cells by a modified Alamar blue
assay [23]. This method measures the redox capacity of the cells
due to the production of metabolites as a result of cell growth
and allows the determination of viability over the culture period
without the detachment of adherent cells. The procedure was op-
timized in order to (i) obtain conditions similar to those found
when applying transdermal patches, i.e. assessment of cell viability
24 h after exposure and 48 h after removing the external agent, (ii)
identify cytotoxicity concentration limits, as well as discriminate
the various surfactants in terms of the respective cytotoxicity.
For this study, gemini surfactants 12-2-12, 12-6-12, 12-10-12
and 14-2-14 were used, and each one tested for the 1, 5, 10, 25
and 50 mM concentrations. Moreover, the corresponding single
tail surfactant DTAB was also employed for comparison. For each
surfactant concentration, five independent assays, each repeated
three times, were performed. Briefly, concentrated solutions of
surfactant were prepared by dissolution in the culture medium
(RPMI-1640), followed by filtration-sterilization using 0.22 mm
pore-diameter filters (Schleicher & Schuell, Dassel, Germany).
Twenty four hours before incubation with surfactants, a cell
suspension was prepared in RPMI-1640 medium and 80610
3
cells/well were seeded in 48-well culture plate. Cells were incu-
bated with the different surfactants, at the various concentrations,
for 24 h under culture conditions (37uC and 5%CO2). After that,
0.3 mL of 10% (v/v) resazurin dye in RPMI-1640 culture medium
was added to each well and, after 1 h of incubation at 37uC,
180 mL of the supernatant were collected from each well and
transferred to 96-well plates. The absorbance at 570 and 600 nm
was measured in a SPECTRAmax PLUS 384 spectrophotometer
(Molecular Devices, Union City, CA) and cell viability (as a
percentage of control cells) calculated according to
(A570{A600)treated cells{(A570{A600)negative control
(A570{A600)positive control{(A570{A600)negative control
|100 ð1Þ
The positive control corresponds to cells not treated with
surfactant, while the negative control corresponds to the same
dilutions of the resazurin dye that was not incubated with cells.
Regarding the recovery assay, cells were maintained in RPMI-
1640 medium free of surfactant, under culture conditions (37uC
and 5%CO2), during a new 48 h period and then submitted again
to the referred cell viability assay.
Leakage
Large unilamellar vesicles (LUV) were prepared from chloro-
form stock solution of L-a-phosphatidylcholine (Chicken Egg PC,
C42H82NO8P, average MW: 770.123), L-a-phosphatidylethanol-
amine (Chicken Egg PE, C41H78NO8P, average MW: 746.608),
L-a-phosphatidylserine (Porcine Brain PS, C42H79NO10P, aver-
age MW: 824.966) and cholesterol (Chol, MW: 386.650). Since
the phospholipids (Avanti Polar Lipids, Alabaster, AL) were
obtained from natural sources, there is a mixture of hydrocarbon
chain length, but acyl chains are mostly composed by 18 carbons,
as established from the molecular formula and average weight of
the components.
Briefly, lipids were mixed at the 1:1:1:1 (PC:PE:PS:Chol) molar
ratio and dried under vacuum in a rotator evaporator. The dried
lipid film was hydrated with 80 mM calcein (Sigma, St. Louis,
MO) in 50 mM HEPES and 1 mM EDTA (pH 8.4), submitted to
3 minutes of sonication, and then extruded 21 times through two
stacked polycarbonate membranes of 100 nm pore diameter,
using a Liposofast device (Avestin, Toronto, Canada), to obtain
large unilamellar liposomes (LUV). Free calcein was separated
from the dye-containing LUV by size exclusion chromatography
on a Sephadex G-75 column, using a buffer (20 mM HEPES,
140 mM NaCl and 1 mM EDTA (pH 7.4)) with the same
Gemini Surfactants: Skin Irritation Effect
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was measured by the Fiske and Subbarow method[31].
Liposome leakage assays were performed on a 96-well opaque
plate, using a liposome concentration of 10 mM and the different
surfactants (DTAB, 12-2-12, 12-10-12 and 14-2-14) in the
concentrations of 5, 25 and 50 mM. The kinetics of leakage of
calcein was followed at 37uC, for 20 minutes, in a SPECTRAmax
Gemini EM fluorimeter (Molecular Devices, Union City, CA),
using the excitation and emission wavelengths of 490 and 520 nm,
respectively. The percentage of leakage was calculated according
to
%Leakage~
F20{F0
Fmax{F0
|100 ð2Þ
where F20 corresponds to the observed fluorescence after 20
minutes of incubation for the liposomes in the presence of sur-
factants, F0 corresponds to fluorescence measured before the
surfactants addiction (liposomes in the absence of surfactants), and
Fmax corresponds to the maximum fluorescence, which was ob-
tained after the complete lysis of liposomes with 0.5% (v/v) Triton
X-100. For each surfactant concentration, two independent assays
(each repeated three times) were performed.
DSC
Mixed liposomes were prepared according to a standard pro-
cedure derived from the original solvent evaporation method [32].
Briefly, lipids (Avanti Polar Lipids, Alabaster, AL) and surfactants
(12-2-12, 12-10-12, 18-2-18) were dissolved in a chloroform/
methanol mixture and dried under reduced pressure to form a
homogeneous thin lipid film. Subsequently, by slowly agitating the
solution inside a bath set to ca. 55uC, the resulting lipid film was
resuspended in 10 mM tris-maleate, 50 mM KCl (pH 7) buffer to
give the desired final lipid concentration. The final solutions were
then subjected to vigorous vortexing conditions and left to
equilibrate overnight inside a bath at a temperature slightly above
the meltingtemperature ofDPPC. Thisapproachhasbeen reported
[6] as adequate to achieve a correct dynamical equilibrium.
DSC was performed on a Perkin Elmer Pyris 1. Volumes of
20 mL of the liposomal suspension containing an average of 2 mg
of DPPC:Chol were sealed in 50 mL aluminium pans. An empty
pan was used as reference [33,34], so as to circumvent frequent
seal breaking induced by vapor pressure created at higher
temperatures, when water-filled pans are used. The samples were
analyzed by heating-cooling cycles at scanning rates of 10uC/min
over the temperature range 10-60uC. For data acquisition and
subsequent analysis of thermograms, the software provided by
Perkin-Elmer was used.
31P-NMR
DPPC liposomes were prepared by the solvent evaporation
method, as previously described for the DSC studies. However, in
this case, deuterated water was used to hydrate the lipid film and
prepare the liposomes. The 12-2-12, 12-10-12 and 18-2-18
gemini, as well as the single tail DTAB, were included in this
part of the work.
31P NMR spectra were acquired on a Varian Spectrometer,
Unity-500 MHz, using a broadband probe. Typical acquisition
parameters consisted of a 90u radiofrequency pulses, 40000 Hz
spectral width and waltz broadband proton decoupling. The dwell
time of 50 ms, and 2000-4000 transients were accumulated for
each free induction decay (FID) with a 3 s relaxation delay. The
31P chemical shifts were referenced externally to 85% H3PO4
(0 ppm). Samples were allowed to equilibrate at least 30 min at a
given temperature before the NMR signal was acquired at 30, 40
and 50uC, according to a standard procedure [25].
Molecular Dynamics simulation
Systems. Following previous work[6], a set of molecular
dynamics performed on the 12-2-12, 12-10-12, 14-2-14 and 18-2-
18 gemini surfactants embedded in a DPPC bilayer was analyzed.
A fully hydrated (1672 SPC water molecules) DPPC bilayer was
generated and equilibrated before the insertion of the surfactant
molecules. A relatively small bilayer, consisting of 72 phospholipid
molecules equally distributed by the two leaflets was built by
placing, in a regular grid, molecules with random rotation around
the major axis. It should be noted that the size of the bilayer was
large enough to accommodate a single embedded surfactant mo-
lecule, and allow the study of the respective interaction with the
surrounding lipids.
Electroneutrality of the overall systems was imposed by adding a
number of chloride ions corresponding to the total positive charge.
It should be noted that, for simplicity, chloride ions were used
instead of bromide because the latter are not implemented in the
original force field. However, qualitative aspects related to the
structure and dynamics are not expected to be significantly influ-
enced, as extracted from similar systems [35].
In order to attain equilibrated systems within the timescale
of the MD, surfactants were directly incorporated in a pre-
equilibrated and fully hydrated DPPC bilayer by substituting one
phospholipid molecule of the previous equilibrated bilayer [6].
Parameters and data analysis. All MD simulations were
carried out in the NpT ensemble and under periodic boundary
conditions, using the GROMACS package, version 3.3.3[36–38],
and the GROMOS 96 53a6 force field [39,40]. A standard time
step of 2 fs was used for both the equilibration and production
runs. Non-bonded interactions were computed on the basis of a
neighbor list, updated every 10 steps. Long-range electrostatics
were computed using the particle mesh Ewald (PME) method,
as recommended for charged membrane simulations [41]. For
Lennard-Jones energies, a cut-off of 1.4 nm was applied. Tem-
perature and pressure were coupled to the Berendsen external
baths maintained at 325 K (ca. 10 K above the gel to liquid
crystalline phase transition of DPPC) and 1 bar (semi-isotropic
pressure coupling, separately applied to the xy plane and z
direction), with coupling constants of 0.1 and 0.5 ps, respectively.
To obtain a starting configuration, each system was firstly sub-
jected to an energy minimization step. The system were then left to
evolve up to 100 ns, using the LINCS algorithm [42] to keep
bonds containing H atoms under positional restraint conditions.
The first 40 ns were considered sufficient to attain equilibrated
systems (converged value of the area per lipid), while the last 60 ns
of production runs were subsequently subjected to standard
analysis, such as atom-atom (group-group) distance distributions
and radial distribution functions (rdf). MD trajectories were
visualized, and configuration images extracted using the VMD
1.8.6 software [43].
Results and Discussion
Very few chemical enhancers for transdermal drug delivery
have been approved for clinical use, due to lack of efficiency or
toxicity concerns. This work compaginates a detailed biophysical
characterization of lipid bilayer-gemini systems with a cytotoxicity
evaluation of the gemini surfactants in a skin irritation model. An
integrated interpretation of the system dynamics and membrane
disruption activity is provided in terms of gemini architecture.
Gemini Surfactants: Skin Irritation Effect
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Since cationic surfactants are known to disturb membrane inte-
grity[4,6], it is important to determine the extent of damage cau-
sed by cationic gemini surfactants.
In what follows, the cytotoxicity of several dicationic gemini
surfactants (12-2-12, 12-6-12, 12-10-12, 14-2-14) was studied, and
compared with a commercial single tail surfactant (DTAB). These
surfactants, selected from previous studies [6,17], were deemed
sufficient to account for variations in the spacer and tail length. It
should be noted that longer tail gemini surfactants, 18-2-18, were
not included in this part of the work due to the low solubility in the
culture medium solution. The NCTC 2544 cell line, a human skin
keratinocyte cell line, was chosen as a model of skin irritation,
while an Alamar blue assay was used to assess the respective cell
viability.
Results for 24 h of exposure are presented in terms of cell
viability, as a percentage of control cells, and depicted in Figure 1.
A first observation indicates that, for the lower concentrations
tested (up to 10 mM), none of the surfactants reveals a significant
cytotoxicity upon the cellular line. However, from 25 mM on-
wards, a strong toxicity is observed for some of them. Regarding
the latter concentration results, from which the cytotoxicity trend
becomes distinguishable for the different surfactants, it is clear that
toxicity is higher for the gemini than for the corresponding single
tail surfactant. Also clear from this representation, is that toxicity
increases as the spacer length increases and that longer tail
surfactants are less toxic than shorter ones.
Although results point to a higher cytotoxicity of gemini sur-
factants than for the corresponding single tail surfactant, it is
possible that an important permeation enhancement occurs for
gemini concentrations below the cytotoxicity limits. In fact, as will
be discussed later, in the majority of the cases gemini surfactants
are more effective in disrupting the membrane than the single-tail
counterpart. This means that a low amount of gemini may be
needed to achieve the same effect of a significantly higher amount
of DTAB.
Attempts to relate the structure of alkylammonium bromide
surfactants and the respective cytotoxicity effects, have been
previously made. It has been shown that the cytotoxicity of
surfactants decreases as the alkyl chain length increases [44,45], in
a trend compatible with the current observations. It has been also
reported that more hydrophilic surfactants (larger head groups)
present a significantly lower cytotoxicity [46]. A relation between
the surfactant structure and the microbicide and contraceptive
properties has been presented [4] for the single-tailed quaternary
ammonium surfactants. In this case, the absolute concentration of
surfactant (controlled by the CMC), is considered crucial for the
respective effect. Results reported suggest that quaternary ammo-
nium surfactants interact differently with different types of cells.
Beyond the alkyl chain length dependence, the presence of specific
polar heads and some counterions are also expected to contribute
for the global toxicity [4,46]. However, as far as polar heads and
counterions are concerned, it is possible to replace them by more
biocompatible ones [19,21,47,48].
Aiming to mimic the recovery process of skin cells after re-
moving an actual transdermal device, cell viability was assessed
48 h after surfactant remotion. Results, as presented in Figure 2,
indicate that for a surfactant concentration higher than 25 mM,
the toxic effect is irreversible, i.e. cell viability does not increase
48 h after removing the surfactant from the culture medium. The
cytotoxicity trend previously discussed is even more clear from this
representation.
Membrane integrity
In order to correlate the cytotoxicity effect of surfactants with
the respective ability to induce cell membrane destabilization, a
liposome leakage assay was performed using liposomes containing
calcein, with a composition that mimic cell membrane, and sur-
factants in the range concentrations used for the cytotoxicity study.
As shown in Figure 3, it is clearly observed that gemini sur-
factants are generally more effective in promoting membrane
destabilization than DTAB. Following an order of increasing
effect, one has the 14-2-14, 12-2-12 and 12-10-12 gemini, with the
latter placed drastically above the others. These observations
suggest that longer tail gemini surfactants are less disruptive, but
that the major effect is associated to the spacer length. For the
range of concentrations under study, the longest hydrophobic
spacer promotes the most significant liposome disruption effect,
which is directly correlated with the higher cytotoxicity effect
induced by this surfactant. These results indicate that most
probably the cytotoxicity promoted by these compounds is, at
least, partially due to their capacity to induce cell membrane
destabilization.
Thermotropic behavior
The impact of cholesterol on biological membranes has been
extensively studied both experimentally [49] and theoretically
[50–52]. Moreover, cholesterol is one of the major components of
Figure 1. Viability of NCTC 2544 cells after 24 h of surfactant exposure. Cell viability values are presented as mean6SD of a characteristic
profile (3 repetitions) selected from 5 independent experiments.
doi:10.1371/journal.pone.0026965.g001
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Therefore, the inclusion of cholesterol in the composition of lipo-
somes to model the skin barrier function has been frequently used
to study skin permeation enhancers [53,54].
A well characterized model of DPPC:Chol was used to evaluate
the effect of gemini surfactants on the respective thermotropic
behavior. Three gemini surfactants (12-2-12, 12-10-12 and 18-2-
18) were used in this part of the work. The fraction of cholesterol
in the lipid composition was supported on a preliminary study,
where an increasing amount of cholesterol (up to 50%) was incor-
porated in a DPPC:Chol mixture (data not presented).
Regarding DPPC bilayers, a heating scan induces a transition
from a highly organized state (gel phase), in which molecular
motions are severely restricted and the alkyl chains of lipids are in
a all-trans conformation, to a state of higher molecular mobility
and conformation disorder (fluid phase), in which the alkyl chains
present gauche defects[55]. The presence of cholesterol produces a
progressive decrease in the temperature of the main phase
transition characteristic of DPPC, which is replaced by a new
asymmetric endothermic event. This has been ascribed to the
overlapping of two symmetric peaks [56,57]. A cooperative
transition, detected by a sharp component originally centered at
40.2uC, is shifted to lower values of temperature as the concen-
tration of cholesterol increases. In turn, a broad component,
centered at a slightly higher temperature, is shifted towards higher
temperatures as the concentration of cholesterol increases, be-
coming undetectable for a cholesterol concentration of ca. 50 -
mol% [58]. The transition energy of the broad component also
increases as Chol concentration increases, reaching a maxi-
mum when the cooperative component vanishes, i.e. close to
20 mol%[58,59]. The existence of two components in the main
transition for Chol concentrations up to 20 mol% suggests phase
separation in the membrane plane, i.e. coexistence of DPPC
domains with a small amount or no cholesterol (sharp transition)
and cholesterol-rich DPPC domains (broad transition). From the
molecular point of view, it has been suggested that cholesterol
molecules are predominantly located in the hydrophobic region of
the bilayer [52]. After occupying the free volume available, that in
fact is known to be higher in the bilayer centre, a consequent
lowering of the conformational freedom of the alkyl chains occurs.
This induces an increase in the lateral area of the membrane that,
in turn, results in some increase of the free volume at the surface.
When the fraction of cholesterol reaches a critical fraction of
5 mol%, cholesterol molecules can move to the lipid/water
interface, compatible with the formation of a new dynamical
structure, denoted as liquid-ordered phase [60], with biological
relevance.
Thus, an amount of 15 mol% of Chol was considered enough to
study the effect of gemini in a lipid model stabilized by the
presence of cholesterol, without completely affecting the original
phase transition of DPPC model, which is convenient to assess the
gemini influence.
Thermograms obtained for DPPC:Chol:12-10-12 system, as
a function of 12-10-12 gemini concentration, are presented in
Figure 4, while values of Tonset and Tmax are summarized in
Table 1. The addition of 5% of 12-10-12 surfactant promotes a
significant broadening of the original transition peak, as well as a
marked decrease of the transition temperature. Increasing the
concentration of gemini up to 15 mol% slightly shifts the transition
temperature to even lower values. After that, for 20 and 25 mol%,
the addition of gemini seems not to significantly increase the effect
upon the model. However, for 30 mol% of gemini, the transition
completely vanishes. These results are an indication of the ability
of the 12-10-12 surfactant to lower the order of the model
membrane, even at a low gemini concentration. Such disordering
effect is compatible with a decrease of the barrier function and,
Figure 3. Membrane destabilization (%± SD) as obtained by
the calcein fluorescent die released from PE:PC:PS:CHO
(1:1:1:1) liposomes, for the indicated surfactant concentra-
tions. Experiments were conducted at room temperature.
doi:10.1371/journal.pone.0026965.g003
Figure 2. Recovery capability of NCTC 2544 cells 48 h after removing surfactants from the culture medium. Cell viability values are
presented as mean6SD of a characteristic profile (3 repetitions) selected from 5 independent experiments.
doi:10.1371/journal.pone.0026965.g002
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membrane may be expected.
Regarding the 12-2-12 surfactant, thermograms are presented
in Figure 5, while the values of the respective transition tem-
peratures are shown in Table 1. Although the trend is similar to
that obtained for the longer spacer surfactant, the effect for the
smallest concentration of surfactant is comparatively small. As the
concentration of gemini increases, a progressive decrease in the
transition temperature and the broadening of the respective peak
are clearly visible. In comparison to the 12-10-12, this shorter
spacer surfactant promotes a broader phase transition, but not the
respective disappearance, even at the highest concentration.
The 18-2-18 surfactant, in turn, was responsible to induce an
opposite effect. As observed in Figure 6, instead of the transition
peak shifting to lower temperatures, this surfactant promotes the
increase in the transition temperature. Furthermore, in the
presence of 30 mol% of this longer tail surfactant, the transition
temperature of the DPPC:Chol model is higher than for the DPPC
model in the absence of cholesterol. These observations indicate
that the longer tail gemini surfactant induces the formation of
more ordered structures.
To summarize, surfactants containing shorter tails (12-10-12
and 12-2-12) promote a decrease in the overall order of the
bilayer, while the opposite effect was found for longer tail
surfactant (18-2-18). Also observed is that, among the shorter tail
surfactants, the one with longer spacer (12-10-12) was responsible
for a more pronounced disrupting effect upon the model
membrane, in accordance with the previous discussed results.
Comparing these results for the DPPC:Chol:gemini systems
with those previous obtained for the DPPC:gemini systems [6],
reveals similar trends. As such, the simpler DPPC model was
chosen in the subsequent NMR and MD studies.
Morphology
In order to check morphological changes induced by gemini
surfactants in a model of lipid membrane,
31P-NMR spectra
were acquired for DPPC liposomes in the presence of DTAB,
12-2-12, 12-10-12, 18-2-18 at three different temperatures (30, 40
and 50uC). Monitoring the
31P heteronucleus present in the
phosphatidic group of DPPC, it is possible to follow changes in the
overall membrane structure [25].
Spectra obtained for the neat DPPC liposomes are presented in
panel (a) of Figure 7. The shape of the peak observed at T=30uCi s
characteristic of a lipid bilayer in the gel phase [61,62]. As the
temperature increases, the peak becomes sharper and the asymmet-
ric shoulder vanishes. This new shape indicates that the dynamic
behavior of the membrane is now characteristic of a fluid-like phase.
As depicted in panel (b), the incorporation of DTAB also pro-
motes some degree of fluidization, now for lower temperatures.
Moreover, there is a visible part of the phosphorus detected at zero
chemical shift. This isotropic behavior may be due to a partial
micellization of original liposome structures, or to conversion into
small vesicles. The bilayer persists, however, even at the highest
temperature (50uC).
This effect is even more visible in the presence of the 12-2-12
surfactant, as depicted in panel (c) of the same Figure. Now, the
fraction of phosphorus presenting an isotropic behavior, coexisting
with the bilayer structure, is higher from the lowest temperature
(30uC) onwards, and a complete conversion is observed for the
higher temperatures, 40 and 50uC. Since the solution is more
viscous and clearer than the corresponding neat DPPC and
DPPC:DTAB ones, a cubic arrangement is a plausible guess. In
fact, the broadening of the basis of the peak and the respective
symmetry, more marked for the highest temperature, is compat-
ible with such a structural arrangement [63].
The gemini surfactant with increased spacer length, 12-10-12,
shows a very distinct effect, panel (d). In this case, the presence of
a longer spacer surfactant promotes from the lowest temperature
(30uC) a dynamic behavior characteristic of a lipid bilayer in the
fluid phase, observed in the neat DPPC system only for the
highest temperature. However, there is no evidence of any
micellization or dissolution of the bilayer structure. In this case,
the solution was slightly opaque with a viscosity similar to those of
DPPC.
The longer tail surfactant, 18-2-18, was very difficult to evaluate
through this method, as a consequence of the occurrence of phase
separation, which is compatible with the more ordered structure
suggested by the other techniques (spectra not presented). This is
confirmed by the white colored, markedly opaque appearence of
the solution, in contrast to that of the neat DPPC solution.
Molecular insight
The MD study focused on the 12-10-12, 12-2-12, 14-2-14 and
18-2-18 gemini surfactants, deemed sufficient for a description of
Figure 4. DSC thermograms of the DPPC:Chol:12-10-12 system
for the lipid:surfactant molar ratios indicated. A scanning rate of
10uC/min was used.
doi:10.1371/journal.pone.0026965.g004
Table 1. Data extracted from the DSC thermograms.
lipid:
surfactant 12-10-12 12-2-12 18-2-18
100:0 38.960.2 40.060.3 40.060.2 41.460.4 41614 2 61
95:5 31.860.1 35.060.2 39624 1 624 2 614 6 62
90:10 31.060.3 3462 35.160.8 4061 43.160.1 46.660.2
85:15 3061 32.560.6 28.060.8 37.360.1 43.860.6 47.460.1
80:20 25642 8 63 28.960.4 31.860.1 45.0560.6 47.660.1
75:25 27652 9 64 28.260.3 30.960.3 48615 0 61
70:30 - - 28.560.1 31.060.2 46614 9 61
Values of Tonset (left columns) and Tmax (right columns), indicated by mean
6SD (minimum of three repetitions), for the detected phase transition,
extracted from the DSC thermograms of DPPC/CHO systems for the indicated
molar percentages. A scanning rate of 10uC/min was used.
doi:10.1371/journal.pone.0026965.t001
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follows previous work by the authors [6,35], in which the 12-2-12,
12-10-12 and the 18-2-18 gemini molecules inserted in DPPC
and DODAB bilayers were studied by molecular dynamics, and
general trends established. In the present work, we provide a de-
tailed quantitative description of the gemini conformation, posi-
tioning within the bilayer and behavior towards the solvent. A new
system, comprising DPPC and the 14-2-14 gemini, was also
included in this study to allow a more direct comparison with the
cytotoxicity results, in which the 18-2-18 gemini was not used due
to insolubility at the relevant concentration range.
Table 2 summarizes some characteristic distances found in the
gemini molecules, and respective positioning relative to the water
interface and bilayer center (see Figure 8 for a schema of the
respective distances). For the 12-2-12, 14-2-14 and 18-2-18
surfactants, it is seen that the head-head distance (dH{H) is highly
controlled by the short spacer, that display a common figure of
0.5 nm. The longer spacer surfactant, 12-10-12, presents a signi-
ficantly larger dH{H, but much shorter than that expected from a
fully extended 10-carbon chain. This suggests that, in this case, the
spacer bends. As the distance from the central carbons of the
spacer to the terminal carbon in the tail (dS{C) is considerably
smaller than the corresponding head-tail distance, it can be con-
cluded that the spacer bends towards the interior of the mem-
brane, as previously suggested [6]. Naturally, no such bending is
possible with the 2-carbon spacers.
In the case of the head-tail distance (dH{C), it is approximately
the same in the 12-2-12, 12-10-12 and 14-2-14 surfactants, and
higher for the 18-2-18 one, as expected. In turn, a longer spacer
promotes a longer distance between the terminal methyl groups
(dC{C). Note that the dH{H for the 2-carbon spacers is roughly
one third of that corresponding to the 10-carbon counterpart,
while the distance between the terminal carbons is one half. The
latter is the quantity in which a larger fluctuation is observed, as
expected from the commonly observed lower order in the central
region of the bilayer.
The analysis of preferential vertical positioning of gemini
molecules embedded in the lipid bilayer relative to the water inter-
face and bilayer centre also show important differences. Heads of
the longer spacer surfactant (12-10-12) are fully embedded in the
membrane, at 0.49 nm from the water interface, while the corre-
sponding shorter spacer molecule (12-2-12) is fixed in a higher
positioning, closer to the interface but yet embedded. In both
cases, the terminal methyl groups of the tails do not reach the
interleaflet bilayer, with 12-2-12 farthest positioned from the core.
In turn, polar heads of the longer tail surfactant (18-2-18) are
almost leveled with the phospholipid polar heads, while the
terminal methyl groups of the tails slightly interdigitate with the
opposite leaflet. The 14-2-14 gemini behaves as an intermediate
case, with the terminal methyl groups reaching further towards the
centre, but not attaining the central part of the bilayer, as the
longest 18-2-18 surfactant.
These results confirm, as already suggested [6,35], that the
interaction behavior of gemini surfactants and model membranes
is dependent on the length of both the spacer and tails. The
described low vertical positioning of the 12-10-12 molecule relative
to the bilayer interface can be explained by some effort of the
system in order to reduce the contact of the hydrophobic spacer
with the polar heads of the phospholipids and water. In fact, when
inserted in the bilayer, the spacer bends towards the respective
interior, as seen in the panel (a) of Figure 9, in which a typical
conformation of the molecule, as extracted from the MD
simulation, is presented. A similar behavior was observed for the
12-2-12 molecule. However, the smaller hydrophobic spacer
allows a higher positioning of the polar heads that, consequently,
promotes the formation of a lower density region close to the
bilayer centre (see panel (b) of Figure 9). This effect, that is
comparatively smaller for the previous longer spacer surfactant, is
compatible with the disordering effect found in the thermotropic
and permeability characterization, extracted from DSC and
leakage assays. Furthermore, the micellization effect observed for
the 12-2-12 surfactant in the morphological studies is expected
from the average conformation and relative vertical positioning
adopted by the 12-2-12 molecule when embedded in the
membrane. A strong reduction of density close to the bilayer
interleaflet suggests an increase of the curvature, compatible with
micelle formation. In the case of the 18-2-18 surfactant, no
evidence of disruption is attained from the simulation results. This
molecule adopts a conformation and a relative vertical positioning
similar to the phospholipids molecules. Moreover, a slight
interdigitation (see panel (c) of Figure 9) can explain some increase
Figure 5. DSC thermograms of the DPPC:Chol:12-2-12 system
for the lipid:surfactant molar ratios indicated. A scanning rate of
10uC/min was used.
doi:10.1371/journal.pone.0026965.g005
Figure 6. DSC thermograms of the DPPC:Chol:18-2-18 system
for the lipid:surfactant molar ratios indicated. A scanning rate of
10uC/min was used.
doi:10.1371/journal.pone.0026965.g006
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2-14 surfactant behaves as an intermediate case of the 12-2-12 and
18-2-18, as previously remarked. An illustrative scheme of the
gemini-membrane interaction, as a function of tail and spacer
length, is depicted in Figure 10.
A further inspection, provided by rdf analyses, was made on the
water accessing the spacer and heads of the gemini molecules. As
extracted from panel (a) of Figure 11, the 12-10-12 gemini
molecule presents a higher amount of water in the proximity of the
respective polar heads. This molecule was found more deeply
inserted in the membrane, with the polar heads further from the
water interface, which could suggest the opposite result. However,
due to a strong local disturbance of the membrane, promoted by
the presence of a long hydrophobic spacer almost leveled with the
polar heads of the phospholipids, the penetration of water is
expected to increase. In contrast, a significant smaller amount of
water was found in the vicinity of the polar heads for both shorter
spacer surfactants, 12-2-12 and 18-2-18. This observation may,
along the same lines, be ascribed to the smaller disruption of the
membrane order at the level of the polar heads. As visible in panel
(b) of the same Figure, the contact of the spacers with water is
significantly smaller than that of the polar heads, and the trend less
trivial. These distributions seem to reflect the vertical positioning
of the spacer relative to the water-membrane interface, rather than
the order in the membrane. The bending conformation of the long
spacer makes the 12-10-12 molecule less accessible to water. In the
case of the short spacer surfactants, 12-2-12 and 18-2-18, water is
found for a smaller radius, with the longer tail surfactant pre-
senting a peak for the smallest radius. Results pertaining to the 14-
2-14 surfactant were very coincident with those obtained for the
short spacer surfactants and, for clarity, were omitted in the
rdf representations. These observations are compatible with the
previous discussion.
In summary, no significancet toxicity was found on the NCTC
2544 cell line for any of the surfactants, in a concentration range
up to 10 mM. From 25 mM onwards, a clear trend indicates that
toxicity is higher for the gemini surfactants than for the corre-
sponding single-tailed surfactant. In terms of surfactant structure,
cytotoxicity increases as the spacer length increases, and decreases
with the increase of tail length. Recovery tests also indicate that for
Figure 7.
31P-NMR spectra of a DPPC:surfactant systems ([DPPC]=30 mg/mL, x(surfactant)=20 mol%), in the (a) absence of
surfactant, and in the presence of (b) DTAB, (c) 12-2-12 and (d) 12-10-12. The chemical shift is represented in the horizontal axis.
doi:10.1371/journal.pone.0026965.g007
Figure 8. Schema of the distances, extracted from the MD, used
to characterize the conformation and relative position of
gemini molecules in the bilayer. A summary of the respective
values for the 12-2-12, 12-10-12, 14-2-14, and 18-2-18 surfactants are
presented in Table 2.
doi:10.1371/journal.pone.0026965.g008
Table 2. Data extracted from the MD simulations.
12-10-12 12-2-12 14-2-14 18-2-18
dH{H/nm 1.460.2 0.560.1 0.560.1 0.560.1
dC{C/nm 1.960.7 1.060.6 0.960.4 0.960.4
dH{C/nm 1.260.1 1.260.1 1.360.1 1.760.1
dS{C/nm 0.960.3 1.260.1 1.360.2 1.760.2
dinterface/nm 0.4960.07 0.2160.02 0.2060.04 0.0960.03
dcentre/nm 0.2160.08 0.3660.04 0.3260.05 -0.1260.04
General data on the average conformation (top of the table) and relative
positioning (bottom of the table) of the indicated gemini molecules inserted in
a fully hydrated DPPC bilayer as extracted from the MD simulation at 325 K. See
Figure 8 for a schema of the respective distances.
doi:10.1371/journal.pone.0026965.t002
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PLoS ONE | www.plosone.org 8 November 2011 | Volume 6 | Issue 11 | e26965Figure 9. Snapshots selected from the MD simulations, illustrating (a) a typical conformation of the 12-10-12 molecule (the long
hydrophobic spacer bending towards the interior of the bilayer), and the positioning of the (b) 12-2-12 and (c) 18-2-18 molecules
relative to the neighboring phospholipid molecules. The larger conformational freedom found close to bilayer centre observed for the short
tail surfactant contrasts with the interdigitation evidence observed for the long tail surfactant.
doi:10.1371/journal.pone.0026965.g009
Figure 10. Pictorial illustration of the positioning and general conformational of gemini molecules embedded in the membrane, as
well as the consequent morphological modification of the latter, based on the
31P-NMR and MD simulation results. From the top to
the bottom, gemini surfactants represented correspond to short spacer/short tail, short spacer/long tail and long spacer/short tail architectures.
doi:10.1371/journal.pone.0026965.g010
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effect is irreversible.
Permeability of liposomes to calcein, in the presence of the same
surfactants, show a similar trend. In this case, the 12-10-12 sur-
factant was responsible for a drastic loss of integrity from the
membrane.
The cationic gemini surfactants under study are able to alter the
thermotropic behavior of the DPPC:Chol model. Shorter tail
surfactants, 12-2-12 and 12-10-12, reduce the temperature of the
original phase transition, which is compatible with a decreasing
membrane order. The opposite effect was found for the longer tail
surfactant, 18-2-18. Regarding spacer length variation, no sig-
nificant differences were observed. However, the longer spacer
surfactant seems to be more effective in the disruption of the mem-
brane for smaller concentrations.
The morphological study returns some clues about the
perturbation mechanism behind gemini surfactants. It seems clear
from the NMR results that shorter tail surfactants are much more
active in terms of perturbation of the original DPPC bilayer
structure than the corresponding longer tail surfactant. Relative to
spacer length, it was suggested that a shorter spacer promotes an
increase of the curvature of the bilayer structure, while a longer
Figure 11. Radial distribution functions of water relative to the (a) gemini polar heads, and (b) gemini spacer, calculated from the
MD. Simulations were carried out at 325 K.
doi:10.1371/journal.pone.0026965.g011
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original bilayer structure.
Molecular dynamics simulation supports the most important
findings on the interaction between the cationic gemini surfactants
with model membranes, and provides insight into the respective
mechanism that governs the interaction between the cationic
gemini surfactants, of variable spacer and tail length, with mem-
branes. From the analysis of various systems, it was possible to
establish a number of factors that contribute for the disrupting
effect of lipid membranes. These factors include preferential
conformation of surfactant molecules embedded in the bilayer
structure and respective positioning relative to the bilayer centre.
Such factors can be directly related to the chemical structure of
surfactants.
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